Skip to main content
. 2018 Sep 24;3(11):1113–1118. doi: 10.1001/jamacardio.2018.3408

Figure 1. Analysis of Treatment Effect According to the Timing of Atorvastatin Before Percutaneous Coronary Intervention (PCI).

Figure 1.

A, 52 Patients did not receive study drug before PCI (25 atorvastatin and 27 placebo). B, 22 Patients did not receive study drug before PCI (10 atorvastatin and 12 placebo). C, 28 Patients did not receive study drug before PCI (14 atorvastatin and 14 placebo).